Business Context and Reporting Period
This Form 8-K filing by IDEAYA Biosciences, Inc. (IDYA) reports a corporate governance event dated June 26, 2025. The company is incorporated in Delaware and trades on The Nasdaq Global Select Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the appointment of a new executive officer:
- Joshua Bleharski, Ph.D. was appointed as Chief Financial Officer and Principal Financial Officer by the Board of Directors on June 26, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is limited to the disclosure of the officer appointment under Item 5.02.
Investor Verification Checklist
- Verify the professional background and prior experience of the newly appointed CFO, Joshua Bleharski, Ph.D.
- Confirm the effective date of the appointment and any associated compensatory arrangements not detailed in this summary.
- Review subsequent filings for any impact of this leadership change on the company's financial strategy or reporting.